Use of Low Molecular Weight Heparin (Tinzaparin) to Treat Blood Clots in Patients With Kidney Failure

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00186745
Recruitment Status : Terminated (Funding ceased)
First Posted : September 16, 2005
Last Update Posted : April 19, 2016
Heart and Stroke Foundation of Ontario
LEO Pharma
Information provided by (Responsible Party):
Wendy Lim, St. Joseph's Healthcare Hamilton

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Primary Completion Date : November 2015
  Study Completion Date : February 2016